Volume Alert - GERN 3.17 Geron Corp $GERN Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GERN 3.17 Geron Corp $GERN Hit a high today of 3.18 Closing the day 10:29 at 3.17 +0.06 +1.93% With a day low of 3.05 and a total volume of 1,418,466.

GERN Recent Posts: http://investorshangout.com/Geron-Corporation-GERN-54220/

GERN Geron Corp Recent Headline News

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 19, 10:23AM CST
Regulatory updates from Gilead (GILD) and Regeneron (REGN) and Geron's (GERN) deal with J&J were the highlights last week in the biotech sector.
GILD: 101.89 (-0.45), GERN: 3.28 (+0.17), CLDX: 20.82 (+2.09), CYTR: 2.59 (-0.04), AMGN: 164.59 (+1.95), ABBV: 65.59 (+0.09), REGN: 413.04 (-2.21)

Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 7:43AM CST
Can the Rally in Geron (GERN) Shares Continue?
GERN: 3.28 (+0.17)

Most active Nasdaq-traded stocks
AP - Tue Nov 18, 12:25PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
GILD: 101.89 (-0.45), FB: 73.62 (+0.29), GERN: 3.28 (+0.17), DNDN: 0.13 (-0.02), SNSS: 2.01 (-0.12), MSFT: 48.45 (+0.23), INTC: 35.47 (+1.12), GRPN: 7.57 (+0.31), AAPL: 116.45 (+1.78), CSCO: 26.73 (+0.14), RFMD: 14.20 (+0.31)

Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA
PR Newswire - Tue Nov 18, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Exelixis Inc. (NASDAQ: EXEL), Geron Corporation (NASDAQ: GERN), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Galena Biopharma Inc. (NASDAQ: GALE), and XOMA Corporation (NASDAQ: XOMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 17, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ Composite closed at 4,671.00, down 0.37%. The S&P 500 finished the session 0.07% higher at 2,041.32. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 781.08, up 0.49%, with the index advancing 9.06% in the previous three months. Register for your complimentary reports on these five stocks at:
DRNA: 10.73 (+0.76), GERN: 3.28 (+0.17), TKMR: 16.04 (-0.08), GALE: 1.86 (+0.05), XOMA: 4.55 (+0.44), EXEL: 1.72 (+0.02)

Incyte Building Blockbuster Drug One Disease At A Time
at Investor's Business Daily - Mon Nov 17, 2:58PM CST
Sometimes, drug launches take a while to get off the ground. Incyte's only approved drug, Jakafi, has been on the market three years, but it's really only just getting started. Jakafi, sold in some markets as Jakavi, is approved for a rare...
JNJ: 107.89 (-0.87), GILD: 101.89 (-0.45), GERN: 3.28 (+0.17), MRK: 59.25 (-0.39), AZN: 74.37 (-1.01), PFE: 30.39 (-0.05), INCY: 71.54 (+0.24), BMY: 58.57 (-0.24), CTIC: 2.18 (unch), NVS: 95.33 (-0.40)

Hot Stock: Geron, Shares Gain 8.7% (GERN)
Comtex SmarTrend(R) - Mon Nov 17, 12:00PM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 8.7% to $3.00 on 2.7x average daily volume. Geron has traded 8.7 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (8.7% to the Dow's -0.1%) and outperformed the S&P 500 (8.7% to the S&P's -0.2%) during today's trading.
GERN: 3.28 (+0.17)

J&J deal stokes Geron
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:42AM CST

GERN: 3.28 (+0.17)

Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal
at The Street - Mon Nov 17, 9:40AM CST
Shares of Geron (GERN) soared in morning trading Monday after the company announced late last week it had licensed its blood disorder drug imetelstat to Johnson & Johnson JNJ.
GERN: 3.28 (+0.17)

Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:25AM CST
Geron (GERN) was a big mover last session, with shares surging over 19% on the day.
BIIB: 301.78 (-1.83), GERN: 3.28 (+0.17), ILMN: 187.29 (-2.74), AFFX: 9.08 (+0.27)

Nasdaq stocks posting largest volume increases
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NVEE: 11.78 (+0.08), GERN: 3.28 (+0.17), RDI: 11.86 (+0.23), RDIB: 11.84 (-0.16)

Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 301.78 (-1.83), JNJ: 107.89 (-0.87), GERN: 3.28 (+0.17), AFFX: 9.08 (+0.27)

Geron Set to Possibly Pullback After Yesterday's Rally of 19.48%
Comtex SmarTrend(R) - Fri Nov 14, 4:49PM CST
Geron (NASDAQ:GERN) traded in a range yesterday that spanned from a low of $2.72 to a high of $3.33. Yesterday, the shares gained 19.5%, which took the trading range above the 3-day high of $2.44 on volume of 31.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GERN: 3.28 (+0.17)

Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 37.77 (+0.49), AMZN: 330.82 (+4.28), JNJ: 107.89 (-0.87), HTZ: 22.71 (+0.53), GERN: 3.28 (+0.17), HAL: 49.08 (+0.65), JWN: 75.09 (+1.28), NOK: 7.78 (+0.04), BHI: 64.14 (+0.63)

Geron to Present at the Stifel Healthcare Conference
Thomson Reuters ONE - Fri Nov 14, 3:15PM CST
MENLO PARK, Calif., November 14, 2014 - Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the Stifel 2014 Healthcare Conference in New York. The presentation is scheduled to occur on Wednesday, November 19th at 1:50 p.m. Eastern Time.
GERN: 3.28 (+0.17)

Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 107.89 (-0.87), GERN: 3.28 (+0.17)

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 37.77 (+0.49), JNJ: 107.89 (-0.87), HTZ: 22.71 (+0.53), VA: 33.75 (+0.54), GERN: 3.28 (+0.17), JWN: 75.09 (+1.28)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST

ZIOP: 3.68 (+0.04), BSPM: 1.31 (+0.02), BDR: 2.02 (-0.10), ZAZA: 2.97 (-0.16), ACY: 8.65 (+0.15), NBS: 4.44 (+0.11), SYRX: 1.24 (-0.03), IAG: 2.26 (+0.05), THTI: 1.20 (-0.03), BITA: 87.40 (-0.73), VRTB: 4.78 (-0.22), OPTT: 1.03 (-0.04), INVT: 0.93 (+0.07), GERN: 3.28 (+0.17), VASC: 25.24 (+0.24), LOCM: 1.49 (+0.04), CTHR: 1.65 (+0.01), MOV: 25.67 (+0.41), IFON: 1.22 (-0.05), SVM: 1.55 (+0.03)

Traders Get Bullish on Shares of Geron, Shares Up 28.6% (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 10:07AM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 28.6% to $2.97 on 5.5x average daily volume. Geron has traded 17.8 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (28.6% to the Dow's -0.0%) and outperformed the S&P 500 (28.6% to the S&P's 0.1%) during today's trading.
GERN: 3.28 (+0.17)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 162

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Snowrise Targets the Blind Spots in CPG Sales Data

Updated Category News Views 35

A sales total can look healthy while the floorboards are quietly rotting underneath it. That is the uncomfortable CPG problem Snowrise is aiming at: brands know what moved last quarter, but often cannot identify which stores, channels, communities, or promotions actually created the result. Plenty of management teams still steer by topline revenue, net distribution gains,...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 10

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 72

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 183

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 117

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 73

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 231

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 194

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 16

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading

Top 5 Most Recently Viewed Articles

AEA Private Debt's Strategic Investment in Weller Metalworks

Updated Category News Views 299

Let's cut to the chase: AEA Private Debt is making some serious waves in the middle market with its latest move as the Sole Provider of mezzanine notes for Weller Metalworks' acquisition of DROP Sprockets, Inc. This isn’t just another deal; it’s a calculated step in an increasingly competitive landscape where metal fabrication firms are vying for supremacy. Weller...

Continue Reading
Medication Management Partners Continues to Excel in Senior Care

Updated Category News Views 196

Medication Management Partners Earns Prestigious Recognition In recent news, Medication Management Partners (MMP), a leading long-term care pharmacy, proudly announces its place on the Inc. 5000 list of fastest-growing private companies in America for the seventh consecutive year. This achievement signifies the company’s steady growth and innovative practices in the...

Continue Reading
AlphaGen Unveils Major Expansion Plans for Power Generation

Updated Category News Views 501

AlphaGen's Ambitious 450 MW Power Generation Initiative Alpha Generation, LLC ("AlphaGen"), based in Stamford, Conn., is taking a significant step towards meeting the escalating demand for reliable electric power across the nation. With plans to add approximately 450 megawatts (MW) of additional electric generation at four existing power stations, AlphaGen aims to bolster...

Continue Reading
STAT Secures a Loeb Award for Outstanding Reporting on Opioids

Updated Category News Views 185

STAT Achieves Recognition for Vital Reporting STAT addiction reporter Lev Facher has been honored with a 2025 Loeb Award for his exceptional work in explanatory reporting. This award, regarded as the pinnacle of accomplishment in business and financial journalism, recognizes Facher's six-part series titled "The War on Recovery." The compelling series sheds light on the...

Continue Reading
Investigation into Nomura Holdings, Inc. Sparks Investor Concerns

Updated Category News Views 67

Introduction to the Investigation of Nomura Holdings, Inc. Pomerantz LLP is currently conducting an investigation focused on claims made on behalf of investors of Nomura Holdings, Inc. (NYSE: NMR). The essence of this investigation revolves around whether Nomura and some of its key officers or directors may have engaged in securities fraud or other illicit business...

Continue Reading